Funder: The Mark Foundation for Cancer Research
Due Dates (Anticipated): September 2026: Letter of Intent deadline (Endeavor Awards) | January 2027: Full application deadline (Endeavor Awards) | January 2027: Letter of Intent deadline (Glioblastoma RFP — ASPIRE/Endeavor)
Funding Amounts: $3,000,000 total over 3 years per Endeavor Award; typically 2 awards per cycle; indirect costs capped at 10%.
Summary: Multidisciplinary cancer research teams are funded to drive innovative advances in prevention, diagnosis, and treatment beyond what individual efforts can achieve.
Key Information: Forecasted dates—verify on program site; institutional submission limits and team requirements apply.